Combivent Respimat ^*

Combivent Respimat (generic name: ipratropium bromide and albuterol) is a bronchodilator that helps dilate the airways for people with chronic obstructive pulmonary disease (COPD). Ipratropium bromide and albuterol combined are indicated for use in patients COPD who are already being treated with a regular aerosol bronchodilator but continue to have evidence of bronchospasm and require a second bronchodilator. Studies have shown that ipratropium bromide and albuterol work together to open the airways more than either can do on its own. NOTE: Combivent Respimat is not intended for treating asthma or relieving acute bronchospasm and doesn’t replace a rescue inhaler.

Dosage

Follow the prescribing doctor’s instructions and the guide printed on the Product Information leaflet that comes with each Combivent Respimat pack. The usual dose is for daily use, up to four inhalations daily, and not exceeding six inhalations in 24 hours.

Storage

Keep the medicine stored at temperatures below 77°F (25°C). Read our blog on handling medicine safely.

FAQ

Is there a cure for COPD?

COPD has no cure. The damage that was done to the lung tissue cannot be reversed. The purpose of Combivent Respimat medication is to reduce the frequency and intensity of attacks caused by a shortage of breath.

Is COPD life-threatening?

The effects of COPD can differ from person to person. Even with careful treatment, COPD may get worse and can pose life-threatening risks. The condition is irreversible, but proper treatment can prevent it from interfering with regular activity.

Is there a difference between COPD and asthma?

Chronic Obstructive Pulmonary Disease (COPD) and asthma both cause inflammation of the bronchi that can result in breathing difficulties. Asthma is more likely triggered by allergies, so the symptoms can be intermittent, and there can be long breaks between attacks. COPD usually involves more persistent symptoms that progressively worsen despite treatment.